Old Web
English
Sign In
Acemap
>
authorDetail
>
Leslie K. Jacobsen
Leslie K. Jacobsen
Bristol-Myers Squibb
Duchenne muscular dystrophy
Medicine
Contractual rights
Physical therapy
Tolerability
4
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1b/2 Study of the Anti-Myostatin Adnectin RG6206 (BMS-986089) in Ambulatory Boys with Duchenne Muscular Dystrophy: A 72-Week Treatment Update (P1.6-062)
2019
Neurology
Kathryn R. Wagner
Brenda L. Wong
Barry J. Byrne
C. Tian
Leslie K. Jacobsen
Giridhar Tirucherai
Michael Rabbia
Heidemarie Kletzl
Juergen Dukart
Rose Ong
Karl Yen
G. Sajeev
James Signorovitch
Susan Ward
Cliff Bechtold
Michelle L. Krishnan
Show All
Source
Cite
Save
Citations (4)
A randomized, placebo-controlled, double-blind, Phase 1b/2 study of the novel antimyostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy (P5.431)
2018
Neurology
Kathryn Rae Wagner
Brenda Wong
Barry J. Byrne
Lee Sweeney
Leslie K. Jacobsen
Giridhar Tirucherai
Michael Rabbia
Jeppe Buchbjerg
Michelle Krishnan
Clifford Bechtold
Show All
Source
Cite
Save
Citations (1)
Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents
2017
Neuromuscular Disorders
Alan S. Robertson
Mark J. Majchrzak
Courtney M. Smith
Robert C. Gagnon
Nino Devidze
Glen B. Banks
Sean C. Little
Fizal Nabbie
Denise I. Bounous
Janet DiPiero
Leslie K. Jacobsen
Linda J. Bristow
Michael K. Ahlijanian
Stephen A. Stimpson
Show All
Source
Cite
Save
Citations (18)
BMS-986089: A novel adnectin protein that dose dependently lowers free myostatin and increases muscle volume and lean body mass
2016
Neuromuscular Disorders
Leslie K. Jacobsen
Clifford Bechtold
Giridhar Tirucherai
Michael K. Ahlijanian
F. Luo
Show All
Source
Cite
Save
Citations (2)
1